Back
ALPS Active Equity Opportunity ETF Vs. Viking Therapeutics Industry Stock Comparison
Buy
54
RFFC
ALPS Active Equity Opportunity ETF
Last Price:
57.23
Seasonality Move:
4.55%
Buy
58
VKTX
Viking Therapeutics
Last Price:
61.63
Seasonality Move:
36.82%
Buy
54
ALPS Active Equity Opportunity ETF (RFFC)
is a Buy
Is ALPS Active Equity Opportunity ETF a Buy, Sell or Hold?
- The current ALPS Active Equity Opportunity ETF [RFFC] share price is $57.53. The Score for RFFC is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- RFFC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
58
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $61.63. The Score for VKTX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- VKTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RFFC Stock Price Chart
What is ALPS Active Equity Opportunity ETF's stock price today?
-
The ALPS Active Equity Opportunity ETF share price today is $57.53
The current trend is moderately bullish and RFFC is experiencing selling pressure, which indicates risk of future bearish movement.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $61.63
The current trend is moderately bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.
RFFC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.6 | Buy |
Relative Strength Index (14 RSI): | 65.85 | Buy |
Chaikin Money Flow: | -553 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (55.54 - 57.16) | Buy |
Bollinger Bands (100): | (53.21 - 56.07) | Buy |
VKTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.12 | Buy |
Relative Strength Index (14 RSI): | 49.26 | Sell |
Chaikin Money Flow: | -1176939 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (57.9 - 66.32) | Sell |
Bollinger Bands (100): | (52.14 - 66.8) | Buy |
RFFC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 57.27 | Buy |
20-day SMA: | 56.37 | Buy |
50-day SMA: | 55.4 | Buy |
200-day SMA: | 52.31 | Buy |
8-day EMA: | 57.23 | Buy |
20-day EMA: | 56.61 | Buy |
50-day EMA: | 55.72 | Buy |
200-day EMA: | 52.34 | Buy |
VKTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 64.66 | Sell |
20-day SMA: | 61.87 | Sell |
50-day SMA: | 59.76 | Buy |
200-day SMA: | 53.91 | Buy |
8-day EMA: | 63.35 | Sell |
20-day EMA: | 62.66 | Sell |
50-day EMA: | 60.77 | Buy |
200-day EMA: | 52.02 | Buy |
ALPS Active Equity Opportunity ETF Earnings Growth & RFFC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.55 per share.
ALPS Active Equity Opportunity ETF Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Viking Therapeutics Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |